Key result
ACC/AHA and ESC guidelines differ in their specific recommendations for managing antiplatelet therapy in patients with acute coronary syndromes.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Note: The review process for this Editorial was fully handled by Christian Weber, Editor in Chief.
No takes yet. Share an insight, caveat, or question.
Lip et al. (2013) studied this question. ACC/AHA and ESC guidelines differ in their specific recommendations for managing antiplatelet therapy in patients with acute coronary syndromes.
Synapse has enriched 10 related papers. Consider them for comparative context: